Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The psoralen receptor is a ~22 kDa protein found in the cell membrane and cytoplasm of various cell types, including skin cells. It binds psoralens, such as 8-MOP, and upon UVA photoactivation, triggers cellular responses like altered proliferation and melanogenesis. It also modulates signaling pathways like EGF receptor, PI3K/Akt, and estrogen receptor signaling, influencing its potential use in treating skin diseases and cancer.
Psoralens bind to a ~22 kDa receptor in the cell membrane or cytoplasm. Upon UVA exposure, the psoralen-receptor complex is photoactivated, leading to photoalkylation of the receptor and downstream signaling changes that affect cell proliferation, differentiation, and melanogenesis. Can also modulate hormone receptor pathways (e.g. estrogen receptor) and P-glycoprotein.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Psoralen Receptor.